NICHOLAS ASPINALL: Open Payments
NPI 1487491296 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $162 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 4 | $68 |
| Edwards Lifesciences Corporation | 1 | $47 |
| La Jolla Pharmaceutical Company | 2 | $43 |
| Baxter Healthcare | 1 | $32 |
| Terumo Cardiovascular Systems Corporation | 1 | $28 |
| ABIOMED | 1 | $17 |
Products named: AMVUTTRA, INSPIRIS RESILIA AORTIC VALVE, GIAPREZA, FLOSEAL, VIRTUOSAPH PLUS WITH RADIAL INDICATION.
Industry payments across MO — which companies pay providers there.
